Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Beran

Showing results (161-170 of 251) with videos related to

Pageof 26
Sort By:
Journal of Behavioral Medicine|September 17, 2020
A prospective study of cancer-related benefit finding in uveal melanoma patientsKate L Herts, Alexandra Jorge-Miller, Tammy M Beran, et al.
Leukemia & Lymphoma|March 28, 1998
CECA-cyclophosphamide, etoposide, carboplatin and cytosine arabinoside--a new salvage regimen for relapsed or refractory acute myelogenous leukemiaS M Kornblau, H Kantarjian, S O'Brien, et al.
Cancer|November 15, 1993
Granulocyte colony-stimulating factor supportive treatment following intensive chemotherapy in acute lymphocytic leukemia in first remissionH M Kantarjian, E Estey, S O'Brien, et al.
The New England Journal of Medicine|February 3, 1994
Lack of effect of 2-chlorodeoxyadenosine therapy in patients with chronic lymphocytic leukemia refractory to fludarabine therapyS O'Brien, H Kantarjian, E Estey, et al.
Leukemia|January 1, 1992
Evolution of treatment for acute myelogenous leukemia and myelodysplastic syndrome at M.D. Anderson Cancer Center 1985-1991M J Keating, E Estey, H Kantarjian, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|July 29, 2021
Visual impairment and depression in uveal melanoma: Optimism and pessimism as moderatorsJames J MacDonald, Alexandra Jorge-Miller, Craig K Enders, et al.
Biochemical Pharmacology|December 1, 1987
Effect of 1-beta-D-arabinofuranosylcytosine (ara-C) on nuclear topoisomerase II activity and on the DNA cleavage and cytotoxicity produced by 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) and etoposide in m-AMSA-sensitive and -resistant human leukemia cellsM Bakic, D Chan, B S Andersson, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|September 13, 2008
The trajectory of psychological impact in BRCA1/2 genetic testing: does time heal?Tammy M Beran, Annette L Stanton, Lorna Kwan, et al.
British Journal of Cancer|January 1, 1990
Resistance to 4-(9-acridinylamino) methanesulphon-m-anisidide (m-AMSA) in human myeloid leukaemiaW L Skinner, D Murray, V Kohli, et al.
Leukemia|June 1, 1995
Fludarabine plus doxorubicin in previously treated chronic lymphocytic leukemiaL E Robertson, S O'Brien, H Kantarjian, et al.
Pageof 26

Showing results (161-170 of 251) with videos related to

Sort By:
Pageof 26
Journal of Behavioral Medicine|September 17, 2020
A prospective study of cancer-related benefit finding in uveal melanoma patientsKate L Herts, Alexandra Jorge-Miller, Tammy M Beran, et al.
Leukemia & Lymphoma|March 28, 1998
CECA-cyclophosphamide, etoposide, carboplatin and cytosine arabinoside--a new salvage regimen for relapsed or refractory acute myelogenous leukemiaS M Kornblau, H Kantarjian, S O'Brien, et al.
Cancer|November 15, 1993
Granulocyte colony-stimulating factor supportive treatment following intensive chemotherapy in acute lymphocytic leukemia in first remissionH M Kantarjian, E Estey, S O'Brien, et al.
The New England Journal of Medicine|February 3, 1994
Lack of effect of 2-chlorodeoxyadenosine therapy in patients with chronic lymphocytic leukemia refractory to fludarabine therapyS O'Brien, H Kantarjian, E Estey, et al.
Leukemia|January 1, 1992
Evolution of treatment for acute myelogenous leukemia and myelodysplastic syndrome at M.D. Anderson Cancer Center 1985-1991M J Keating, E Estey, H Kantarjian, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|July 29, 2021
Visual impairment and depression in uveal melanoma: Optimism and pessimism as moderatorsJames J MacDonald, Alexandra Jorge-Miller, Craig K Enders, et al.
Biochemical Pharmacology|December 1, 1987
Effect of 1-beta-D-arabinofuranosylcytosine (ara-C) on nuclear topoisomerase II activity and on the DNA cleavage and cytotoxicity produced by 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) and etoposide in m-AMSA-sensitive and -resistant human leukemia cellsM Bakic, D Chan, B S Andersson, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|September 13, 2008
The trajectory of psychological impact in BRCA1/2 genetic testing: does time heal?Tammy M Beran, Annette L Stanton, Lorna Kwan, et al.
British Journal of Cancer|January 1, 1990
Resistance to 4-(9-acridinylamino) methanesulphon-m-anisidide (m-AMSA) in human myeloid leukaemiaW L Skinner, D Murray, V Kohli, et al.
Leukemia|June 1, 1995
Fludarabine plus doxorubicin in previously treated chronic lymphocytic leukemiaL E Robertson, S O'Brien, H Kantarjian, et al.
Pageof 26